Cargando…
The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial
BACKGROUND: Lower extremity artery disease (LEAD) is greatly harmful to Type 2 Diabetes Mellitus patients. Traditional Chinese Medicine (TCM) is an alternative therapy to delay the development of macrovascular diseases, but the existing evidence of its efficacy, safety and mechanism of action is ins...
Autores principales: | Leng, Yulin, Gao, Hong, Fu, Xiaoxu, Xie, Hongyan, Hu, Zhipeng, Zhu, Jianwei, Liu, Xiaoke, Zhou, Xiujuan, Xie, Ziyan, Xie, Chunguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220098/ https://www.ncbi.nlm.nih.gov/pubmed/32011447 http://dx.doi.org/10.1097/MD.0000000000018713 |
Ejemplares similares
-
Efficacy and safety of Chinese herbal medicine on blood glucose fluctuations in patients with type 2 diabetes mellitus: A protocol of systematic review and meta-analysis
por: Leng, Yulin, et al.
Publicado: (2020) -
Network Pharmacology-Based Identification of the Mechanisms of Shen-Qi Compound Formula in Treating Diabetes Mellitus
por: Hu, Zhipeng, et al.
Publicado: (2020) -
Efficacy and safety of Lian-Hua Qing-Wen granule for COVID-2019: A protocol for systematic review and meta-analysis
por: Hu, Zhipeng, et al.
Publicado: (2020) -
Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol
por: Leng, Yulin, et al.
Publicado: (2022) -
Clinical observation of Dan-Hong Hua-Yu oral solution in treating retinal vein occlusion
por: Li, Tie-Jun, et al.
Publicado: (2020)